Teva Pharmaceutical Industries Ltd

Latest stories

1d
The Register NorthJersey.com
Anger over EpiPen prompts offer of $300 discount from drugmakerearlier this year, the FDA found “major deficiencies” in a quest for a competin
Anger over EpiPen prompts offer of $300 discount from drugmaker
The Register NorthJersey.com / Posted yesterday
earlier this year, the FDA found “major deficiencies” in a quest for a competing generic version of the EpiPen produced by Teva Pharmaceutical Industries Ltd. It is delayed until at least 2017. State Sen. Richard Codey, D-Essex, who wrote a letter... Read more
585 related stories
1d
Market Watch
After Mylan uproar, a generic EpiPen could hit the market in 2017on Mylan may push the FDA to accelerate applications for generic versions of th
After Mylan uproar, a generic EpiPen could hit the market in 2017
Market Watch / Posted yesterday
on Mylan may push the FDA to accelerate applications for generic versions of the drug, with most of the hope resting on Teva Pharmaceutical Industries Ltd. TEVA, +0.04% “We suspect the FDA will be under pressure to enable a more competitive... Read more
31 related stories
2d
Newsmax
Hillary Clinton's Attacks on Drug Prices Leave Health Stocks Reeling& Co. in New York. He mostly blamed the dip after Clinton’s statement to sensit
Hillary Clinton's Attacks on Drug Prices Leave Health Stocks Reeling
Newsmax / Posted 2 days ago
& Co. in New York. He mostly blamed the dip after Clinton’s statement to sensitivity surrounding health stocks generally. Teva Pharmaceutical Industries Ltd. is also working on a generic competitor that could benefit from a sped-up review as a... Read more
585 related stories
2d
Newsmax
Clinton's Attacks on Drug Pricing Leave Health Stocks Reeling& Co. in New York. He mostly blamed the dip after Clinton’s statement to sensit
Clinton's Attacks on Drug Pricing Leave Health Stocks Reeling
Newsmax / Posted 2 days ago
& Co. in New York. He mostly blamed the dip after Clinton’s statement to sensitivity surrounding health stocks generally. Teva Pharmaceutical Industries Ltd. is also working on a generic competitor that could benefit from a sped-up review as a... Read more
585 related stories
2d
Business Wire
Teva Confirms PTAB’s Decisions on Two Patents in IPR Challenge to COPAXONE® 40 mgJERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:
Teva Confirms PTAB’s Decisions on Two Patents in IPR Challenge to COPAXONE® 40 mg
Business Wire / Posted 2 days ago
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today confirmed the Patent Trial and Appeal Board (PTAB) decisions from an Inter Partes Review (IPR) to invalidate all claims of the ‘250 and ‘413 patents for 40 mg... Read more
9d
Business Wire
European Commission Grants Marketing Authorization for Teva’s CINQAERO® (reslizumab)JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:
European Commission Grants Marketing Authorization for Teva’s CINQAERO® (reslizumab)
Business Wire / Posted 9 days ago
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the European Commission has granted marketing authorization for CINQAERO® (reslizumab) in the 28 countries of the European Union (EU) in... Read more
10d
Roll Call
Pharmaceutical Lobby Shakeup Precedes Drug Price Battleabout the group's future despite the tumult. He pointed to new member companies
Pharmaceutical Lobby Shakeup Precedes Drug Price Battle
Roll Call / Posted 10 days ago
about the group's future despite the tumult. He pointed to new member companies including the big Israeli drugmaker Teva Pharmaceutical Industries Ltd. and Alexion Pharmaceuticals Inc., both of which he says will help PhRMA amplify its... Read more
15d
Orange County Register
Allergan to buy vision company for $95 millionbased in Dublin but has offices in Irvine and New Jersey, completed the $40.5 b
Allergan to buy vision company for $95 million
Orange County Register / Posted 15 days ago
based in Dublin but has offices in Irvine and New Jersey, completed the $40.5 billion sale of its generic drugs business to Teva Pharmaceutical Industries Ltd. last week. Allergan was based in Irvine until it was acquired for about $70 billion by... Read more
19d
The Globe and Mail
Allergan revenue disappoints as Alzheimer drug loses exclusivityin the pharmaceutical industry. Allergan said last week it would sell its Anda
Allergan revenue disappoints as Alzheimer drug loses exclusivity
The Globe and Mail / Posted 19 days ago
in the pharmaceutical industry. Allergan said last week it would sell its Anda distribution business for $500-million to Teva Pharmaceutical Industries Ltd , a day after the Israeli drugmaker completed the $40.5-billion acquisition of Allergan’s... Read more
2 related stories
21d
The Chattanoogan
Attorney General Announces Settlement With Pharmaceutical Company That Engaged In Anti-Competitive Conductand the District of Columbia, reached a $125 million settlement with Cephalon,
Attorney General Announces Settlement With Pharmaceutical Company That Engaged In Anti-Competitive Conduct
The Chattanoogan / Posted 21 days ago
and the District of Columbia, reached a $125 million settlement with Cephalon, Inc. and affiliated companies, now part of Teva Pharmaceutical Industries. The settlement ends a multistate investigation into alleged anticompetitive conduct by... Read more
10 related stories
22d
Crain's Detroit Business
Michigan to get $3.4 million in settlement with drugmakerbought the drug Provigil. The settlement ends a multistate investigation into
Michigan to get $3.4 million in settlement with drugmaker
Crain's Detroit Business / Posted 22 days ago
bought the drug Provigil. The settlement ends a multistate investigation into conduct by Cephalon, a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., that delayed generic versions of Provigil from entering the market for years, caus... Read more
8 related stories
22d
New Kerala
Dr Reddy's acquires Teva's 8 US products - newkerala.com #100510Ltd on Thursday said it has completed acquisition of eight Abbreviated New Drug
Dr Reddy's acquires Teva's 8 US products - newkerala.com #100510
New Kerala / Posted 22 days ago
Ltd on Thursday said it has completed acquisition of eight Abbreviated New Drug Applications (ANDAs) in the US from Teva Pharmaceutical Industries Ltd and an affiliate of Allergan plc. The acquired portfolio consists of products that are... Read more
2 related stories
23d
Channel NewsAsia
Biogen not pursuing a saleonce a successor is named. Meanwhile, Allergan recently announced the closing
Biogen not pursuing a sale
Channel NewsAsia / Posted 23 days ago
once a successor is named. Meanwhile, Allergan recently announced the closing of a deal to sell its generics business to Teva Pharmaceutical Industries Ltd for more than US$40 billion, providing Allergan with a substantial war chest that could be... Read more
17 related stories
23d
Reuters
Biogen not pursuing a saleonce a successor is named. Meanwhile, Allergan recently announced the closing
Biogen not pursuing a sale
Reuters / Posted 23 days ago
once a successor is named. Meanwhile, Allergan recently announced the closing of a deal to sell its generics business to Teva Pharmaceutical Industries Ltd (TEVA.TA) for more than $40 billion, providing Allergan with a substantial war chest that... Read more
17 related stories
23d
Business Wire
Global Nanomedicine Market Analysis & Trends Report 2016 - Market is Poised to Grow to Reach Approximately $1.3 Trillion by 2025Healthcare - Johnson & Johnson - Mallinckrodt plc - Merck & Co. Inc. - Nano
Global Nanomedicine Market Analysis & Trends Report 2016 - Market is Poised to Grow to Reach Approximately $1.3 Trillion by 2025
Business Wire / Posted 23 days ago
Healthcare - Johnson & Johnson - Mallinckrodt plc - Merck & Co. Inc. - Nanosphere Inc. - Pfizer Inc. - Sigma-Tau Pharmaceuticals Inc. - Smith & Nephew PLC - Stryker Corp - Teva Pharmaceutical Industries Ltd. - UCB (Union chimique belge)... Read more
6 related stories
23d
NBC Philadelphia
Teva Completes $40.5B Actavis DealA day after completing its $40.5 billion purchase of Allergan’s generic pharmac
Teva Completes $40.5B Actavis Deal
NBC Philadelphia / Posted 23 days ago
A day after completing its $40.5 billion purchase of Allergan’s generic pharmaceuticals business, Teva Pharmaceutical Industries Ltd. has entered into a definitive agreement to purchase Anda Inc., a subsidiary of Allergan, for $500 million. Anda is... Read more
4 related stories
23d
Reuters
Biogen not pursuing a saleonce a successor is named. Meanwhile, Allergan recently announced the closing
Biogen not pursuing a sale
Reuters / Posted 23 days ago
once a successor is named. Meanwhile, Allergan recently announced the closing of a deal to sell its generics business to Teva Pharmaceutical Industries Ltd (TEVA.TA) for more than $40 billion, providing Allergan with a substantial war chest that... Read more
17 related stories
23d
Business Wire
Dr. Reddy’s Completes Acquisition of Product Portfolio from TEVAcompleted the previously announced acquisition of eight Abbreviated New Drug Ap
Dr. Reddy’s Completes Acquisition of Product Portfolio from TEVA
Business Wire / Posted 23 days ago
completed the previously announced acquisition of eight Abbreviated New Drug Applications (ANDAs) in the U.S. from Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) (TASE: TEVA) and an affiliate of Allergan plc (NYSE: AGN). The acquired... Read more
2 related stories
24d
Reuters
Allergan to sell Anda drug distribution business to TevaExchange (NYSE) April 6, 2016. Allergan Plc (AGN.N) said it would sell its And
Allergan to sell Anda drug distribution business to Teva
Reuters / Posted 24 days ago
Exchange (NYSE) April 6, 2016. Allergan Plc (AGN.N) said it would sell its Anda Inc distribution business to Israel's Teva Pharmaceutical Industries Ltd (TEVA.TA) for $500 million, a day after Teva completed its $40.5 billion acquisition of... Read more
4 related stories
24d
FOX Business
Teva To Buy Allergan's Anda Inc. Distribution Business For $500 MlnTeva Pharmaceutical Industries Ltd. plans to buy Allergan PlC's Anda Inc. distr
Teva To Buy Allergan's Anda Inc. Distribution Business For $500 Mln
FOX Business / Posted 24 days ago
Teva Pharmaceutical Industries Ltd. plans to buy Allergan PlC's Anda Inc. distribution business for $500 million, Allergan said Wednesday morning. Anda Inc. distributes a variety of pharmaceutical products but particularly generic pharmaceuticals,... Read more
4 related stories
24d
FOX Business
Teva To Buy Allergan's Anda Inc. Distribution Business For $500 MlnTeva Pharmaceutical Industries Ltd. plans to buy Allergan PlC's Anda Inc. distr
Teva To Buy Allergan's Anda Inc. Distribution Business For $500 Mln
FOX Business / Posted 24 days ago
Teva Pharmaceutical Industries Ltd. plans to buy Allergan PlC's Anda Inc. distribution business for $500 million, Allergan said Wednesday morning. Anda Inc. distributes a variety of pharmaceutical products but particularly generic pharmaceuticals,... Read more
4 related stories
24d
Channel NewsAsia
Teva completes US$40b purchase of Allergan generics arma move the Israeli firm hailed as confirmation of its intention to become one o
Teva completes US$40b purchase of Allergan generics arm
Channel NewsAsia / Posted 24 days ago
a move the Israeli firm hailed as confirmation of its intention to become one of the world's largest drug manufacturers. "Teva Pharmaceutical Industries Ltd. and Allergan plc today announced that Teva has completed its acquisition of Allergan's... Read more
3 related stories
24d
Bangkok Post - Thailand's English news
Teva completes $40 bn purchase of Allergan generics armlargest manufacturer of generic drugs -- non-branded, cheaper alternatives to b
Teva completes $40 bn purchase of Allergan generics arm
Bangkok Post - Thailand's English news / Posted 24 days ago
largest manufacturer of generic drugs -- non-branded, cheaper alternatives to branded drugs that have lost their patent "Teva Pharmaceutical Industries Ltd. and Allergan plc today announced that Teva has completed its acquisition of Allergan's... Read more
3 related stories
24d
Business Wire
Teva Completes Acquisition of Actavis GenericsJERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:
Teva Completes Acquisition of Actavis Generics
Business Wire / Posted 24 days ago
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Allergan plc (NYSE: AGN) today announced that Teva has completed its acquisition of Allergan’s generics business (“Actavis Generics”). This strategic... Read more
3 related stories

People in this news